Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country

Moye-Holz, D., van Dijk, J. P., Reijneveld, S. A. & Hogerzeil, H. V., 1-Aug-2017, In : Globalization and health. 13, 1, 10 p., 53.

Research output: Contribution to journalArticleAcademicpeer-review

Background: The World Health Organization recommends establishing and implementing a national pharmaceutical policy (NPP) to guarantee effective and equitable access to medicines. Mexico has implemented several policy approaches to regulate the pharmaceutical sector, but it has no formal NPP. This article describes the approach that the Mexican government has taken to improve availability and affordability of essential medicines.

Methods: Descriptive policy analysis of public pharmaceutical policy proposals and health action plans on the basis of publicly available data and health progress reports, with a focus on availability and affordability of medicines.

Results: The government has implemented pooled procurement, price negotiations, and an information platform in the public sector to improve affordability and availability. The government mainly reports on the savings that these strategies have generated in the public expenditure but their full impact on availability and affordability has not been assessed.

Conclusions: To increase availability and affordability of medicines in the public sector, the Mexican government has resorted on isolated strategies. In addition to efficient procurement, price negotiations and price information, other policy components and pricing interventions are needed. All these strategies should be included in a comprehensive NPP.

Original languageEnglish
Article number53
Number of pages10
JournalGlobalization and health
Issue number1
Publication statusPublished - 1-Aug-2017


  • Medicines, Availability, Affordability, Policy, Mexico, Middle-income country, Price negotiations, Pooled procurement, UNIVERSAL HEALTH COVERAGE, PHARMACEUTICAL POLICY, PUBLIC PROCUREMENT, ACCESS, PRICES, BRAZIL, DRUGS, CARE

Download statistics

No data available

ID: 46678941